RESEARCH DEVELOPMENT THERAPEUTIC

Brand Owner (click to sort) Address Description
CISLEUKIN INHIBRX, INC. Suite 200 11025 North Torrey Pines Road La Jolla CA 92037 Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals;
DALCOR Dalcor Pharma UK Ltd 3rd Floor, 1 Ashley Road, Altrincham Cheshire WA14 2DT United Kingdom Research and development of therapeutic drugs in the field of biopharmaceuticals;
FIT-FOR-FUNCTION INHIBRX, LP 11099 NORTH TORREY PINES ROAD SUITE 280 LA JOLLA CA 92037 Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals;
IDEA TO DRUG TENIUM THERAPEUTICS, INC. 11025 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals;
INHIBRX INHIBRX, INC. Suite 200 11025 North Torrey Pines Road La Jolla CA 92037 Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals;
INHIBRX INHIBRX, LP 11099 NORTH TORREY PINES ROAD SUITE 280 LA JOLLA CA 92037 Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals;
KYMERA Kymera Therapeutics, Inc. 200 Arsenal Yards Blvd., Suite 230 Watertown MA 02472 Research and development of therapeutic drugs for the treatment of oncology, autoimmune, immune-oncology and other related diseases; Research and development of pharmaceuticals, and research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Medical research for development of therapeutic modalities for treatment of diseases; Clinical studies; Preclinical and clinical development of therapeutic products;
MIRAGEN miRagen Therapeutics, Inc. 6200 Lookout Road Boulder CO 80301 Research and development of therapeutic drugs for treatment of cardiovascular and muscle disease;
MYOGEN Myogen, Inc. 7577 West 103rd Avenue Suite 212 Westminster CO 800215426 Research and development of therapeutic drugs for the treatment of heart muscle disease;
NEXT GENERATION MEDICINES NGM Biopharmaceuticals, Inc. 333 Oyster Point Boulevard South San Francisco CA 94080 Research and development of therapeutic drugs in the field of biopharmaceuticals;
SYNLOGIC Synlogic, Inc. 301 Binney Street, Suite 402 Cambridge MA 02142 Research and development of therapeutic and diagnostic products using engineered or biologically modified microbes;
VAST-MAB TENIUM THERAPEUTICS, INC. 11025 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A bacterial ?1,3-fucosyltransferase gene and deduced amino acid sequence is provided. The gene is useful for preparing ?1,3-fucosyltransferase polypeptide, and active fragment thereof, which can be used in the production of oligosaccharides such as Lewis X, Lewis Y, and siayl Lewis X, which are structurally similar to certain tumor-associated carbohy-drate antigens found in mammals. These product glycoconjugates also have research and diagnostic utility in the development of assays to detect mammalian tumors. In addition the polypeptide of the invention can be used to develop diagnostic and research assays to determine the presence of H. pylori in human specimens.